For Clinicians
In Good Energy provides licensed psychotherapy and clinical hypnotherapy for patients in or completing ketamine-assisted treatment. This page is for referring prescribers, medical directors, and KAP clinic teams considering integration partners.
The fit
Active KAP integration is most effective when the patient has a clinician trained specifically in working with altered states—someone who can hold the clinical scaffolding a 30-minute medical visit doesn't have time for, without competing for the prescribing relationship.
This practice was built for that role:
Licensed Mental Health Counselor (NY) with diagnostic privilege—full clinical scope for treating mental health conditions, not a coach
Certified Clinical Hypnotherapist (CCHT) with formal in-person training in trance-based intervention
NYU-trained, in clinical practice since 2018
Telehealth across New York State, with limited in-person availability in downtown NYC
I do not provide medical management. The work I do is collateral to your treatment.
How I work alongside your team
Coordination of care. With patient authorization, I provide brief written check-ins or attend coordination calls as helpful.
HIPAA-compliant communication. Secure email and a verified client portal.
Outcome tracking. Sessions tracked with validated instruments—PHQ-9, GAD-7, PCL-5, and ASRS-v1.1 as clinically indicated. Outcome data available to referring clinicians on request.
Superbill handling. Patients receive monthly superbills directly for out-of-network reimbursement; you and your billing team are not involved.
Scope clarity. I refer back to you for medication questions, dose adjustments, and any concern requiring medical assessment.
programs
Three structures, all telehealth-deliverable:
Single Integration Session—for one-off post-journey work or testing fit.
Integration Intensive—six 90-minute sessions over 8–10 weeks; for patients in active KAP treatment or focused post-journey work. Includes between-session voice memo access and a custom hypnotherapy recording.
Full Journey Program—twelve sessions over 4–6 months; preparation, integration, and stabilization across a full treatment arc.
Full program detail here: ingoodenergy.com/ketamine-integration
Selected research informing the work
Full research list at ingoodenergy.com/ketamine-integration
-
Wilkinson et al., 2021 — Psychotherapy and Psychosomatics · Yale School of Medicine
Cognitive Behavioral Therapy to Sustain the Antidepressant Effects of Ketamine in Treatment-Resistant Depression: A Randomized Clinical Trial
Patients with treatment-resistant depression received six IV ketamine infusions over three weeks. Those who achieved clinical response — defined as 50% or greater improvement in depression severity — were then randomized to either CBT or treatment as usual for an additional 14 weeks. The CBT group showed a moderate effect size advantage in sustained remission at the end of the study period (Cohen’s d = 0.65). The authors explicitly identify ketamine’s neuroplasticity window — the time-limited period following infusion during which synaptic reorganization occurs — as the biological rationale for why structured psychotherapy is more effective when delivered in sequence with ketamine rather than in isolation. A 2017 preliminary version of the same study by the same lead author produced consistent findings, establishing CBT as a viable strategy for extending ketamine’s antidepressant effects without ongoing drug exposure.
-
Dore et al., 2019 — Journal of Psychoactive Drugs
The largest real-world outcomes study of ketamine-assisted psychotherapy to date, drawing on data from 235 patients across three clinical practices. Unlike infusion-only models — where ketamine’s psychedelic properties are treated as unwanted side effects to be minimized — all three practices in this study intentionally incorporated psychotherapy alongside ketamine administration, using the expanded state as a therapeutic resource rather than a pharmacological inconvenience. Findings showed meaningful reductions in depression, anxiety, and PTSD across the patient sample, with particularly strong results in older patients and those presenting with severe symptom burden. The authors conclude that KAP is an effective approach for a wide range of diagnoses in private practice settings — and that ketamine’s value extends well beyond the infusion room when paired with structured clinical support.
-
Joneborg I, Lee Y, Di Vincenzo JD, et al. Active mechanisms of ketamine-assisted psychotherapy: A systematic review. Journal of Affective Disorders. 2022;315:105–112.
A 2022 systematic review of five randomized trials of ketamine-assisted psychotherapy found significant positive effects on primary outcome measures versus controls; the authors propose that ketamine's temporary neural changes—NMDA receptor inhibition and increased synaptic neuroplasticity—create a window in which structured therapeutic work produces more durable change than the medicine alone. The review supports a now-foundational argument in the field: integration isn't adjunctive; it's how ketamine's effects become lasting.
Adults in New York State
In active KAP treatment, post-treatment integration, or preparing to begin
Capable of and committed to outpatient therapy work
Self-pay or out-of-network reimbursement; no in-network insurance contracts
If a referred patient isn't the right fit, I refer back with two or three alternative options.
What makes for a good referral
REFER A PATIENT
Email therapy@ingoodenergy.com with:
Patient name (or initials, if pre-introduction)
One-line clinical context
Best way to reach them once the introduction is made
I respond within two business days.
For first-time referrers, I'm happy to do a 15-minute intro call—for you, not the patient—to walk through how I work and answer any questions before you send your first referral.
— Amanda K. Reilly, LMHC-D, CCHT